ArticleThe Lancet. Rheumatology2024

Effectiveness of a fourth mRNA dose among individuals with systemic autoimmune rheumatic diseases during the Omicron era.

Jessica Widdifield et al.PubMed ↗Publisher ↗

No numbers read from the abstract.